Optimal Management of Conventional Adenomas in 2026: Current and Evolving Recommendations and Ongoing Controversies.

IF 2.7 4区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Bianca Thakkar, Rachael Hagen, Joseph C Anderson
{"title":"Optimal Management of Conventional Adenomas in 2026: Current and Evolving Recommendations and Ongoing Controversies.","authors":"Bianca Thakkar, Rachael Hagen, Joseph C Anderson","doi":"10.1097/MCG.0000000000002356","DOIUrl":null,"url":null,"abstract":"<p><p>Adenomas are the most common precancerous colorectal lesions detected during colonoscopy. The techniques, endoscopic tools, and recommendations for detection, resection, and surveillance continue to change. This review summarizes current practice regarding detection and resection as well as national and international guidelines for screening, surveillance intervals, and recommended resection techniques, while highlighting areas where recommendations diverge or remain uncertain. We discuss key controversies shaping clinical decision-making, including topics such as the use of all-examination versus screening-specific adenoma detection rate (ADR) thresholds, the impact of computer-aided polyp detection (CADe) on quality benchmarks, and the debated significance of villous features or high-grade dysplasia in guiding follow-up intensity. We use the calendar year 2026 as the reference starting point for optimal adenoma management. In our review, we integrate current guideline recommendations with emerging evidence and ongoing shifts in endoscopic practice, rather than relying on anticipated formal guideline updates. By synthesizing established standards with new data and advancing technologies, this review provides a practical overview to support gastroenterologists in optimizing adenoma management and applying guideline-based care.</p>","PeriodicalId":15457,"journal":{"name":"Journal of clinical gastroenterology","volume":" ","pages":"588-602"},"PeriodicalIF":2.7000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MCG.0000000000002356","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Adenomas are the most common precancerous colorectal lesions detected during colonoscopy. The techniques, endoscopic tools, and recommendations for detection, resection, and surveillance continue to change. This review summarizes current practice regarding detection and resection as well as national and international guidelines for screening, surveillance intervals, and recommended resection techniques, while highlighting areas where recommendations diverge or remain uncertain. We discuss key controversies shaping clinical decision-making, including topics such as the use of all-examination versus screening-specific adenoma detection rate (ADR) thresholds, the impact of computer-aided polyp detection (CADe) on quality benchmarks, and the debated significance of villous features or high-grade dysplasia in guiding follow-up intensity. We use the calendar year 2026 as the reference starting point for optimal adenoma management. In our review, we integrate current guideline recommendations with emerging evidence and ongoing shifts in endoscopic practice, rather than relying on anticipated formal guideline updates. By synthesizing established standards with new data and advancing technologies, this review provides a practical overview to support gastroenterologists in optimizing adenoma management and applying guideline-based care.

2026年传统腺瘤的最佳管理:当前和不断发展的建议和持续的争议。
腺瘤是结肠镜检查中最常见的结直肠癌前病变。技术、内镜工具以及检测、切除和监测的建议都在不断变化。这篇综述总结了目前关于检测和切除的实践,以及关于筛查、监测间隔和推荐切除技术的国家和国际指南,同时强调了建议存在分歧或仍不确定的领域。我们讨论了影响临床决策的关键争议,包括全面检查与筛查特异性腺瘤检出率(ADR)阈值的使用,计算机辅助息肉检测(CADe)对质量基准的影响,以及绒毛特征或高度不典型增生在指导随访强度方面有争议的意义。我们使用2026年作为最佳腺瘤管理的参考起点。在我们的综述中,我们将当前的指南建议与新出现的证据和内窥镜实践中的持续变化结合起来,而不是依赖于预期的正式指南更新。通过综合现有标准与新数据和先进技术,本综述提供了一个实用的概述,以支持胃肠病学家优化腺瘤管理和应用指南为基础的护理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of clinical gastroenterology
Journal of clinical gastroenterology 医学-胃肠肝病学
CiteScore
5.60
自引率
3.40%
发文量
339
审稿时长
3-8 weeks
期刊介绍: Journal of Clinical Gastroenterology gathers the world''s latest, most relevant clinical studies and reviews, case reports, and technical expertise in a single source. Regular features include cutting-edge, peer-reviewed articles and clinical reviews that put the latest research and development into the context of your practice. Also included are biographies, focused organ reviews, practice management, and therapeutic recommendations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书